Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms. [electronic resource]
Producer: 20080331Description: 65-73 p. digitalISSN:- 1342-1751
- 8-Hydroxy-2'-Deoxyguanosine
- Adult
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Ataxia Telangiectasia Mutated Proteins
- Biomarkers -- blood
- Cell Cycle Proteins -- genetics
- DNA Damage -- drug effects
- Deoxyguanosine -- analogs & derivatives
- Enalapril -- therapeutic use
- Female
- Humans
- Kidney Transplantation -- methods
- Lipid Peroxidation
- Losartan -- therapeutic use
- Male
- Malondialdehyde -- blood
- Peptidyl-Dipeptidase A -- genetics
- Polymorphism, Genetic
- Protein Serine-Threonine Kinases -- genetics
- Renin-Angiotensin System -- genetics
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.